Skip to the page

Data / Drug companies / Tobramycin

Tobramycin: 41 companies and 57 products in the FDA NDC directory

Tobramycin is listed in the FDA National Drug Code Directory by 41 companies, with 57 products in commercial distribution. 51 of the products (89.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; solution/ drops; injection, and the newest product started marketing on July 15, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
41
Products
57
Generic (ANDA) products
51 (89.5%)
Application numbers
28
Routes
Ophthalmic, Respiratory (inhalation), Intravenous, Intramuscular, Oral
Brand names
Kitabis Pak, Bethkis, Tobrex, Tobi, Tobi Podhaler
openFDA record search
api.fda.gov

Companies that list tobramycin

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Gland Pharma Limited5injection; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)May 18, 2021
NorthStar RxLLC3solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 1, 2024
Proficient Rx LP3solution; solution/ dropsGeneric drugs (ANDA)January 31, 1996
A-S Medication Solutions2solution/ drops; solutionGeneric drugs (ANDA)August 11, 2020
Asclemed USA, Inc.2solution; solution/ dropsGeneric drugs (ANDA)June 28, 2017
Baxter Healthcare Corporation2injectionGeneric drugs (ANDA)July 15, 2016
Lifestar Pharma LLC2solutionGeneric drugs (ANDA)June 30, 2023
Mylan Institutional LLC2injectionGeneric drugs (ANDA)August 19, 2014
Preferred Pharmaceuticals Inc.2solution; solution/ dropsGeneric drugs (ANDA)July 15, 2026
Sportpharm LLC2solution; solution/ dropsGeneric drugs (ANDA)August 11, 2020
Viatris Specialty LLC2solution; capsuleNew drug applications (NDA)June 23, 2022
Advanced Rx of Tennessee, LLC1solutionGeneric drugs (ANDA)May 24, 2023
American Health Packaging1solutionGeneric drugs (ANDA)May 19, 2024
Amneal Pharmaceuticals LLC1solutionGeneric drugs (ANDA)July 13, 2014
Ascend Laboratories, LLC1solutionGeneric drugs (ANDA)April 2, 2021
Aurobindo Pharma Limited1solutionGeneric drugs (ANDA)January 22, 2021
Bausch & Lomb Incorporated1solutionGeneric drugs (ANDA)November 29, 1993
Belcher Pharmaceuticals, LLC1solution/ dropsGeneric drugs (ANDA)April 1, 2024
Chiesi USA, Inc.1solutionNew drug applications (NDA)April 15, 2013
Direct RX1solution/ dropsGeneric drugs (ANDA)April 23, 2019
Eugia US LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)June 21, 2023
Fosun Pharma USA Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 11, 2021
Genericus, Inc.1solutionAuthorized generics (NDA)July 11, 2016
Hospira, Inc.1injection, solutionGeneric drugs (ANDA)May 5, 2005
Jvet Pharmaceuticals LLC1solution/ dropsGeneric drugs (ANDA)January 26, 2026
Lupin Pharmaceuticals, Inc.1solutionGeneric drugs (ANDA)June 12, 2018
Novartis Pharmaceuticals Corporation1ointmentNew drug applications (NDA)June 28, 1981
NuCare Pharmaceuticals, Inc.1solutionGeneric drugs (ANDA)November 29, 1993
NuCare Pharmaceuticals,Inc.1solution/ dropsGeneric drugs (ANDA)June 28, 2017
Pari Respiratory Equipment, Inc.1solutionNew drug applications (NDA)February 19, 2015
Proficient Rx LP1solution/ dropsGeneric drugs (ANDA)July 5, 2017
Remedyrepack Inc.1solution/ dropsGeneric drugs (ANDA)August 13, 2018
Ritedose Pharmaceuticals, LLC1solutionGeneric drugs (ANDA)March 25, 2025
Sandoz Inc1solutionGeneric drugs (ANDA)January 9, 1995
Slate Run Pharmaceuticals, LLC1injection, powder, for solutionGeneric drugs (ANDA)February 1, 2023
Somerset Therapeutics, LLC1solution/ dropsGeneric drugs (ANDA)August 11, 2020
St. Mary's Medical Park Pharmacy1solution/ dropsGeneric drugs (ANDA)September 12, 2019
Sun Pharmaceutical Industries, Inc.1solutionGeneric drugs (ANDA)February 28, 2020
Teva Pharmaceuticals USA, Inc.1solutionGeneric drugs (ANDA)November 19, 2013
XGen Pharmaceuticals DJB, Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 17, 2001
Xiromed, LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 12, 2021

Dosage forms

Dosage formProductsShare
Solution2645.6%
Solution/ drops1424.6%
Injection712.3%
Injection, powder, lyophilized, for solution610.5%
Injection, powder, for solution11.8%
Injection, solution11.8%
Ointment11.8%
Capsule11.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)5189.5%
New drug applications (NDA)58.8%
Authorized generics (NDA)11.8%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.